Maureen Cleary

5.4k total citations
90 papers, 3.2k citations indexed

About

Maureen Cleary is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Maureen Cleary has authored 90 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Clinical Biochemistry, 40 papers in Molecular Biology and 40 papers in Physiology. Recurrent topics in Maureen Cleary's work include Metabolism and Genetic Disorders (41 papers), Lysosomal Storage Disorders Research (26 papers) and Mitochondrial Function and Pathology (24 papers). Maureen Cleary is often cited by papers focused on Metabolism and Genetic Disorders (41 papers), Lysosomal Storage Disorders Research (26 papers) and Mitochondrial Function and Pathology (24 papers). Maureen Cleary collaborates with scholars based in United Kingdom, United States and Germany. Maureen Cleary's co-authors include David R. Thorburn, Xenia Dennett, Avihu Boneh, C.W. Chow, François P. Bernier, J. E. Wraith, Anupam Chakrapani, Ashok Vellodi, Paul Harmatz and Uma Ramaswami and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Analytical Chemistry.

In The Last Decade

Maureen Cleary

86 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Cleary United Kingdom 26 1.6k 1.6k 1.3k 503 452 90 3.2k
Melissa Wasserstein United States 35 1.4k 0.8× 840 0.5× 1.9k 1.4× 529 1.1× 354 0.8× 93 3.3k
Julia B. Hennermann Germany 27 1.0k 0.6× 1.0k 0.6× 892 0.7× 368 0.7× 279 0.6× 95 2.1k
Vassili Valayannopoulos France 39 1.5k 0.9× 1.4k 0.9× 2.0k 1.5× 900 1.8× 834 1.8× 125 4.7k
Alessandro P. Burlina Italy 33 1.1k 0.7× 823 0.5× 1.9k 1.4× 681 1.4× 657 1.5× 113 3.3k
Silvia Tortorelli United States 30 1.0k 0.6× 1.1k 0.7× 621 0.5× 364 0.7× 151 0.3× 70 2.3k
Olaf A. Bodamer United States 34 1.4k 0.8× 1.0k 0.6× 1.9k 1.4× 913 1.8× 701 1.6× 156 4.2k
Federica Deodato Italy 23 801 0.5× 608 0.4× 640 0.5× 404 0.8× 217 0.5× 55 1.7k
Diego Martinelli Italy 30 1.5k 0.9× 1.4k 0.9× 421 0.3× 433 0.9× 120 0.3× 105 3.0k
Guillem Pintos‐Morell Spain 25 490 0.3× 449 0.3× 1.3k 1.0× 526 1.0× 558 1.2× 94 2.2k
Xuefan Gu China 27 1.4k 0.8× 888 0.6× 487 0.4× 515 1.0× 200 0.4× 217 2.5k

Countries citing papers authored by Maureen Cleary

Since Specialization
Citations

This map shows the geographic impact of Maureen Cleary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Cleary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Cleary more than expected).

Fields of papers citing papers by Maureen Cleary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Cleary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Cleary. The network helps show where Maureen Cleary may publish in the future.

Co-authorship network of co-authors of Maureen Cleary

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Cleary. A scholar is included among the top collaborators of Maureen Cleary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Cleary. Maureen Cleary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muschol, Nicole, İlyas Okur, Fatih Süheyl Ezgü, et al.. (2022). A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B. Journal of Clinical Investigation. 133(2). 9 indexed citations
2.
Forny, Patrick, Emma Footitt, James Davison, et al.. (2021). Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era. Neurology Genetics. 7(3). e597–e597. 16 indexed citations
3.
Moinuddin, Md, et al.. (2021). Long‐term cognitive and psychosocial outcomes in adults with phenylketonuria. Journal of Inherited Metabolic Disease. 44(6). 1353–1368. 35 indexed citations
4.
Cleary, Maureen, James Davison, Tarekegn Geberhiwot, et al.. (2021). Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England. Orphanet Journal of Rare Diseases. 16(1). 38–38. 19 indexed citations
5.
Baruteau, Julien, Stephanie Grünewald, Marta Zancolli, et al.. (2019). Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment. Metabolites. 9(11). 275–275. 3 indexed citations
6.
Whitley, Chester B., Maureen Cleary, Eugen Mengel, et al.. (2018). Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B. The Journal of Pediatrics. 197. 198–206.e2. 25 indexed citations
7.
Wijburg, Frits A., Chester B. Whitley, Joseph Muenzer, et al.. (2018). Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial. Molecular Genetics and Metabolism. 126(2). 121–130. 37 indexed citations
8.
Reid, Emma, Apostolos Papandreou, Suzanne Drury, et al.. (2016). Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. Brain. 139(11). 2844–2854. 27 indexed citations
9.
Cleary, Maureen, et al.. (2016). Swallow Prognosis and Follow-Up Protocol in Infantile Onset Pompe Disease. JIMD Reports. 33. 11–17. 10 indexed citations
10.
Tan, Ee Shien, Catharine John, Enzo Ranieri, et al.. (2014). Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8year journey from pilot to current program. Molecular Genetics and Metabolism. 113(1-2). 53–61. 55 indexed citations
11.
Broomfield, Alexander, et al.. (2014). Reversal of Respiratory Failure in Both Neonatal and Late Onset Isolated Remethylation Disorders. JIMD Reports. 16. 51–56. 8 indexed citations
12.
Wedatilake, Yehani, et al.. (2013). A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. American Journal of Medical Genetics Part A. 161(9). 2334–2338. 36 indexed citations
13.
Fassone, Elisa, Jan‐Willem Taanman, Iain P. Hargreaves, et al.. (2011). Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy. Journal of Medical Genetics. 48(10). 691–697. 50 indexed citations
14.
Muenzer, Joseph, J. E. Wraith, Michael Beck, et al.. (2006). A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine. 8(8). 465–473. 457 indexed citations
15.
Cleary, Maureen, Nataliya V. Uboha, Marina R. Picciotto, & Robert D. Beech. (2006). Expression of ezrin in glial tubes in the adult subventricular zone and rostral migratory stream. Neuroscience. 143(3). 851–861. 19 indexed citations
16.
Cleary, Maureen, François Feillet, F. White, et al.. (2006). Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. European Journal of Clinical Nutrition. 60(7). 915–920. 27 indexed citations
17.
Cleary, Maureen, J H Walter, Bronwyn Kerr, & J. E. Wraith. (2002). Facial appearance in glycogen storage disease type III. Clinical Dysmorphology. 11(2). 117–120. 5 indexed citations
18.
White, S. L., Veronica Collins, Rory Wolfe, et al.. (1999). Genetic Counseling and Prenatal Diagnosis for the Mitochondrial DNA Mutations at Nucleotide 8993. The American Journal of Human Genetics. 65(2). 474–482. 157 indexed citations
19.
Delatycki, M. B., Maureen Cleary, Agnes Bankier, et al.. (1997). A maternally transmitted lethal neonatal progeroid syndrome with prominent genitourinary and gastrointestinal features.. Journal of Medical Genetics. 34(6). 520–524. 5 indexed citations
20.
Cleary, Maureen & J. E. Wraith. (1991). Antenatal diagnosis of inborn errors of metabolism.. Archives of Disease in Childhood. 66(7 Spec No). 816–822. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026